• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用聚乙烯醇作为聚合基质的熔融沉积成型法制备 3D 打印片剂以实现快速药物释放。

Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, New York 11439.

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, New York 11439.

出版信息

J Pharm Sci. 2020 Apr;109(4):1558-1572. doi: 10.1016/j.xphs.2020.01.015. Epub 2020 Jan 29.

DOI:10.1016/j.xphs.2020.01.015
PMID:32004538
Abstract

In this study, the processability of polyvinyl alcohol (PVA), a water-soluble polymer, into melt-extruded filaments and then into 3D printed tablets by fused deposition modeling was studied. PVA is semicrystalline with Tg and m.p. of ~45°C and ~190°C, respectively. After screening several plasticizers, sorbitol was selected to enhance melt extrudability of PVA. Carvedilol and haloperidol, 2 basic compounds with pH-dependent solubility, were used as model drugs. Miscibility of the drugs with PVA, with and without added sorbitol as plasticizer, was also tested to determine whether any amorphous solid dispersion was formed that would facilitate rapid and pH-independent dissolution. Finally, the drug release from physical mixtures, crushed extrudates, and printed tablets were determined. Owing to high m.p. and high melt viscosity of PVA, filaments containing 10% and 20% drug required 180°C-190°C for extrusion, which could be reduced to ~150°C by adding 10% sorbitol. The printing temperature of 210°C was, however, required. Miscibility of carvedilol and haloperidol with PVA were, respectively, ~20% and <10%. PVA provided complete drug release from 3D printed tablets with 10% and 20% carvedilol and 60% infill in ~45 min at both pH 2 and 6.8. However, despite relatively rapid dissolution rate, high processing temperature and limited drug-polymer miscibility could be potential development issues with PVA.

摘要

在这项研究中,研究了水溶性聚合物聚乙烯醇(PVA)的可加工性,将其熔融挤出成纤维,然后通过熔融沉积建模 3D 打印成片剂。PVA 是半结晶的,Tg 和 m.p. 分别约为 45°C 和 190°C。在筛选了几种增塑剂后,选择山梨糖醇来提高 PVA 的可熔融挤出性。卡维地洛和氟哌啶醇是两种具有 pH 依赖性溶解度的碱性化合物,被用作模型药物。还测试了药物与 PVA 的混溶性,有无添加山梨糖醇作为增塑剂,以确定是否形成任何无定形固体分散体,从而促进快速和 pH 独立的溶解。最后,测定了物理混合物、挤出物粉碎物和打印片剂的药物释放。由于 PVA 的高熔点和高熔体粘度,含有 10%和 20%药物的纤维需要 180°C-190°C 才能挤出,而添加 10%山梨糖醇可将挤出温度降低至约 150°C。然而,需要 210°C 的打印温度。卡维地洛和氟哌啶醇与 PVA 的混溶性分别约为 20%和 <10%。PVA 提供了 10%和 20%卡维地洛和 60%填充率的 3D 打印片剂的完全药物释放,在 pH 2 和 6.8 下约 45 分钟内完全释放药物。然而,尽管具有相对较快的溶解速率,但高加工温度和有限的药物-聚合物混溶性可能是 PVA 的潜在发展问题。

相似文献

1
Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release.利用聚乙烯醇作为聚合基质的熔融沉积成型法制备 3D 打印片剂以实现快速药物释放。
J Pharm Sci. 2020 Apr;109(4):1558-1572. doi: 10.1016/j.xphs.2020.01.015. Epub 2020 Jan 29.
2
Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.熔融沉积建模的快速药物释放 3D 打印片剂的配方:用于药物释放、药物-聚合物混溶性和可印刷性筛选的聚合物。
J Pharm Sci. 2018 Jan;107(1):390-401. doi: 10.1016/j.xphs.2017.10.021. Epub 2017 Oct 21.
3
Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction.通过酸碱弱相互作用提高 FDM 3D 打印片剂的药物释放速率、药物-聚合物混溶性、可印刷性和可加工性。
Int J Pharm. 2023 Feb 5;632:122542. doi: 10.1016/j.ijpharm.2022.122542. Epub 2022 Dec 22.
4
Development of FDM 3D-printed tablets with rapid drug release, high drug-polymer miscibility and reduced printing temperature by applying the acid-base supersolubilization (ABS) principle.应用酸碱超增溶(ABS)原理开发具有快速药物释放、高药物-聚合物混溶性和降低打印温度的 FDM 3D 打印片剂。
Int J Pharm. 2021 May 1;600:120524. doi: 10.1016/j.ijpharm.2021.120524. Epub 2021 Mar 26.
5
Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler.从载药聚乙烯醇和水溶性或水不溶性聚合物填充剂组成的 3D 打印复合片剂中控制药物释放。
Int J Pharm. 2018 May 30;543(1-2):361-367. doi: 10.1016/j.ijpharm.2018.03.057. Epub 2018 Mar 29.
6
Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.释放调节剂在熔融沉积成型(FDM)3D 打印片剂中调节药物释放的作用。
Int J Pharm. 2021 Mar 15;597:120315. doi: 10.1016/j.ijpharm.2021.120315. Epub 2021 Feb 1.
7
Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.通过熔融沉积建模开发难溶性药物的即释 3D 打印剂型:形态、固态和溶解研究。
Int J Pharm. 2021 Apr 15;599:120417. doi: 10.1016/j.ijpharm.2021.120417. Epub 2021 Feb 27.
8
Drug Incorporation into Polymer Filament Using Simple Soaking Method for Tablet Preparation Using Fused Deposition Modeling.采用简单浸泡法将药物掺入聚合物长丝,用于熔融沉积成型的片剂制备。
Biol Pharm Bull. 2019;42(10):1753-1760. doi: 10.1248/bpb.b19-00482.
9
An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.一项关于使用聚合物共混物来改善通过熔融沉积建模(FDM)3D打印制备的药物固体分散体的可印刷性并调节其药物释放的研究。
Eur J Pharm Biopharm. 2016 Nov;108:111-125. doi: 10.1016/j.ejpb.2016.08.016. Epub 2016 Sep 2.
10
Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets.基于 PVA 的片剂的药物产品熔融挤出 3D 打印:微观结构分析和药物释放特性。
Int J Pharm. 2016 Nov 30;514(1):290-295. doi: 10.1016/j.ijpharm.2016.06.021.

引用本文的文献

1
Biofunctional Excipients: Their Emerging Role in Overcoming the Inherent Poor Biopharmaceutical Characteristics of Drugs.生物功能性辅料:它们在克服药物固有的不良生物药剂学特性方面的新兴作用。
Pharmaceutics. 2025 May 1;17(5):598. doi: 10.3390/pharmaceutics17050598.
2
Development of 3D-Printed Two-Compartment Capsular Devices for Pulsatile Release of Peptide and Permeation Enhancer.3D 打印双室囊泡装置用于脉冲式释放肽类药物和渗透增强剂
Pharm Res. 2024 Nov;41(11):2259-2270. doi: 10.1007/s11095-024-03785-0. Epub 2024 Nov 1.
3
Evaluation of Printability of PVA-Based Tablets from Powder and Assessment of Critical Rheological Parameters.
基于粉末的聚乙烯醇片剂可印刷性评估及关键流变学参数测定
Pharmaceutics. 2024 Apr 19;16(4):553. doi: 10.3390/pharmaceutics16040553.
4
Polyvinyl Alcohol, a Versatile Excipient for Pharmaceutical 3D Printing.聚乙烯醇,一种用于药物3D打印的多功能辅料。
Polymers (Basel). 2024 Feb 14;16(4):517. doi: 10.3390/polym16040517.
5
Bibliometric Analysis-Based Review of Fused Deposition Modeling 3D Printing Method (1994-2020).基于文献计量分析的熔融沉积成型3D打印方法综述(1994 - 2020年)
3D Print Addit Manuf. 2024 Feb 1;11(1):383-405. doi: 10.1089/3dp.2021.0046. Epub 2024 Feb 15.
6
Development of a Bilayer Tablet by Fused Deposition Modeling as a Sustained-Release Drug Delivery System.通过熔融沉积建模开发双层片剂作为缓释药物递送系统。
Pharmaceuticals (Basel). 2023 Sep 19;16(9):1321. doi: 10.3390/ph16091321.
7
3D-printed dosage forms for oral administration: a review.3D 打印口服给药剂型:综述。
Drug Deliv Transl Res. 2024 Feb;14(2):312-328. doi: 10.1007/s13346-023-01414-8. Epub 2023 Aug 24.
8
A Review on Physicochemical Properties of Polymers Used as Filaments in 3D-Printed Tablets.聚合物的物理化学性质综述:作为 3D 打印片剂中丝材的应用。
AAPS PharmSciTech. 2023 May 9;24(5):116. doi: 10.1208/s12249-023-02570-3.
9
Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.快速溶解的熔融沉积成型3D打印片剂开发中的挑战、现状及新兴策略:综述与评论
ADMET DMPK. 2023 Jan 1;11(1):33-55. doi: 10.5599/admet.1622. eCollection 2023.
10
Drop-on-powder 3D printing of amorphous high dose oral dosage forms: Process development, opportunities and printing limitations.无定形高剂量口服剂型的粉末上液滴3D打印:工艺开发、机遇与打印限制
Int J Pharm X. 2022 Dec 23;5:100151. doi: 10.1016/j.ijpx.2022.100151. eCollection 2023 Dec.